A First in Human study assessing the safety, tolerability and pharmacokinetics (blood levels) of gerilimzumab against placebo
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2019
Price : $35 *
At a glance
- Drugs Gerilimzumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; First in man
- Sponsors RuiYi
- 16 Mar 2016 Results published in Bird Rock Bio, Inc media release.
- 22 Jan 2016 Status changed from active, no longer recruiting to completed, as per Australian & NZ Clinical Trials Register.
- 29 Oct 2015 Status changed from recruiting to active, no longer recruiting, as per Australian & NZ Clinical Trials Register.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History